A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group
Clinical trial NCT05937750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05937750
- Sponsor
- Hansa Biopharma AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2030-04-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.